When I took a call from MJA Editor Martin Van Der Weyden asking me to write a “Power of One” article for the Christmas issue of the Journal, I was excited and honoured. Here was an opportunity to reflect on the drivers and influences that led me first into medicine, then diabetes and public health advocacy.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
Correspondence:
- 1. Herzog P. In the shadow of the black eagle: memories of Tarnopol in 1939–1945. Tel Aviv: Yaron Golan, 1996.
- 2. Hetzel BS. The challenge of public health in Australia and the region. Med J Aust 2006; 185: 646-650. <MJA full text>
- 3. Zimmet P, Breidahl HD. Intestinal lymphangiectasia with hypomagnesaemic tetany. Australas Ann Med 1968; 17: 265-269.
- 4. Zimmet P, Breidahl HD, Nayler WG. Plasma ionized calcium in hypomagnesaemia. Br Med J 1968; 1: 622-623.
- 5. Ng FM, Zimmet PZ, Seiler G, et al. Insulin potentiating action of a peptide fraction from human urine. Diabetes 1974; 23: 950-956.
- 6. Paule SG, Nikolovski B, Gray RE, et al. GHTD-amide: a naturally occurring beta cell-derived peptide with hypoglycemic activity. Peptides 2009; 30: 955-961.
- 7. Prior IA, Rose BS, Harvey HP, Davidson F. Hyperuricaemia, gout, and diabetic abnormality in Polynesian people. Lancet 1966; 1: 333-338.
- 8. Zimmet P, Taft P, Guinea A, et al. The high prevalence of diabetes mellitus on a Central Pacific island. Diabetologia 1977; 13: 111-115.
- 9. Koestler A. The call-girls. London: Pan Books, 1976.
- 10. Tuomi T, Groop LC, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993; 42: 359-362.
- 11. Hettiarachchi KD, Zimmet PZ, Myers MA. Transplacental exposure to bafilomycin disrupts pancreatic islet organogenesis and accelerates diabetes onset in NOD mice. J Autoimmun 2004; 22: 287-296.
- 12. Dowse GK, Gareeboo H, Zimmet PZ, et al. High prevalence of NIDDM and impaired glucose intolerance in Indian, Creole, and Chinese Mauritians. Diabetes 1990; 39: 390-396.
- 13. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787.
- 14. Barnett M, Collier GR, Collier FM, et al. A cross-sectional and short-term longitudinal characterisation of NIDDM in Psammomys obesus. Diabetologia 1994; 37: 671-676.
- 15. McCarty DJ, Zimmet P, Dalton A, et al. The rise and rise of diabetes in Australia, 1996: a review of statistics, trends and costs. Canberra: International Diabetes Institute and Diabetes Australia, 1996.
- 16. Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829-834.
- 17. Gregory AT, Armstrong RM, Grassi TD, et al. On our selection: Australian longitudinal research studies. Med J Aust 2008; 189: 650-657.
- 18. Rudd K. Australia 2020 — setting our nation’s sights for the future. Address to the Sydney Institute Annual Dinner 2008 [transcript]. 16 April 2008. http://www.pm.gov.au/node/5836 (accessed Nov 2009).
- 19. Sicree R, Shaw J, Zimmet P. The global burden of diabetes. Diabetes and impaired glucose tolerance: prevalence and projections. In: Gan D, editor. Diabetes atlas. 2nd ed. Brussels: International Diabetes Federation, 2003: 15-71.
- 20. National Preventative Health Taskforce. Australia: the healthiest country by 2020. National Preventative Health Strategy. Canberra: Commonwealth of Australia, 2009.
Online responses are no longer available. Please refer to our instructions for authors page for more information.